- Home
- DIT vs CUE Comparison
DIT vs CUE Comparison
Compare DIT & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DIT
- CUE
- Stock Information
- Founded
- DIT 1981
- CUE 2014
- Country
- DIT United States
- CUE United States
- Employees
- DIT N/A
- CUE N/A
- Industry
- DIT Food Distributors
- CUE Biotechnology: Pharmaceutical Preparations
- Sector
- DIT Consumer Discretionary
- CUE Health Care
- Exchange
- DIT Nasdaq
- CUE Nasdaq
- Market Cap
- DIT 75.2M
- CUE 61.1M
- IPO Year
- DIT 1995
- CUE 2018
- Fundamental
- Price
- DIT $115.00
- CUE $0.59
- Analyst Decision
- DIT
- CUE Strong Buy
- Analyst Count
- DIT 0
- CUE 2
- Target Price
- DIT N/A
- CUE $3.00
- AVG Volume (30 Days)
- DIT 314.0
- CUE 395.3K
- Earning Date
- DIT 11-07-2025
- CUE 11-12-2025
- Dividend Yield
- DIT 0.88%
- CUE N/A
- EPS Growth
- DIT N/A
- CUE N/A
- EPS
- DIT 0.92
- CUE N/A
- Revenue
- DIT $2,254,788,287.00
- CUE $7,100,000.00
- Revenue This Year
- DIT N/A
- CUE N/A
- Revenue Next Year
- DIT N/A
- CUE N/A
- P/E Ratio
- DIT $125.00
- CUE N/A
- Revenue Growth
- DIT 5.29
- CUE N/A
- 52 Week Low
- DIT $94.92
- CUE $0.54
- 52 Week High
- DIT $163.75
- CUE $1.75
- Technical
- Relative Strength Index (RSI)
- DIT 45.45
- CUE 37.67
- Support Level
- DIT $116.54
- CUE $0.57
- Resistance Level
- DIT $117.45
- CUE $0.62
- Average True Range (ATR)
- DIT 0.99
- CUE 0.07
- MACD
- DIT -0.08
- CUE -0.01
- Stochastic Oscillator
- DIT 21.26
- CUE 17.71
About DIT AMCON Distributing Company
Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.